Anna Protopapas Insider Trading $ARIA ARIAD PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anna Protopapas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anna Protopapas. Anna Protopapas is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Senior Vice President in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and President & CEO in Mersana Therapeutics, Inc. ($MRSN) and President and CEO in Mersana Therapeutics, Inc. ($MRSN) and Director in Bioverativ Inc. ($BIVV).
Anna Protopapas in ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anna Protopapas: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Anna Protopapas in ARIAD PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, BIVV, DRNA, MRSN, MLNM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Option Exercise | D | 23.82 | 25,000 | 595,500 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Option Exercise | D | 4.91 | 25,000 | 122,750 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Option Exercise | D | 8.87 | 75,000 | 665,250 | 0 | |
| Feb 16 2017 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Sell | D | 0.00 | 41,910 | 0 | 0 | 41.9 K to 0 (-100.00 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Option Exercise | A | 23.82 | 25,000 | 595,500 | 25,000 | |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Grant | A | 0.00 | 12,500 | 0 | 41,910 | 29.4 K to 41.9 K (+42.50 %) |
| Feb 01 2017 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Grant | A | 0.00 | 5,508 | 0 | 29,410 | 23.9 K to 29.4 K (+23.04 %) |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 03 2016 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Grant | A | 0.00 | 23,902 | 0 | 23,902 | 0 to 23.9 K |
| Apr 30 2015 | ARIA | ARIAD PHARMACEUTIC ... | Protopapas Anna | Director | Option Exercise | A | 8.87 | 75,000 | 665,250 | 75,000 |
Page: 1